These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 33685080)

  • 1. [Novel vector preS1-tp fusion protein effectively inhibits hepatitis B virus replication and cccDNA synthesis by mediating hepatitis B virus targeting sequence small interfering RNA].
    Zeng YL; Gao F; Zhang C; Wei JF; Ma L; Ding GG; Li W; Shang J; Kang Y
    Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):126-132. PubMed ID: 33685080
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficient delivery of HBV NLS siRNAs into HepG2.2.15 cells for HBV inhibition through novel recombinant preS1‑tP proteins.
    Zeng Y; Li Z; Shang J; Kang Y
    Int J Mol Med; 2018 Aug; 42(2):1181-1189. PubMed ID: 29786106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
    Sheraz M; Cheng J; Tang L; Chang J; Guo JT
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.
    Qi Y; Gao Z; Xu G; Peng B; Liu C; Yan H; Yao Q; Sun G; Liu Y; Tang D; Song Z; He W; Sun Y; Guo JT; Li W
    PLoS Pathog; 2016 Oct; 12(10):e1005893. PubMed ID: 27783675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic Analysis of Nuclear Hepatitis B Virus Relaxed Circular DNA-Associated Proteins Identifies UV-Damaged DNA Binding Protein as a Host Factor Involved in Covalently Closed Circular DNA Formation.
    Marchetti AL; Zhang H; Kim ES; Yu X; Jang S; Wang M; Guo H
    J Virol; 2022 Jan; 96(2):e0136021. PubMed ID: 34705558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.
    Ko C; Chakraborty A; Chou WM; Hasreiter J; Wettengel JM; Stadler D; Bester R; Asen T; Zhang K; Wisskirchen K; McKeating JA; Ryu WS; Protzer U
    J Hepatol; 2018 Dec; 69(6):1231-1241. PubMed ID: 30142426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
    Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
    Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PreS1BP mediates inhibition of Hepatitis B virus replication by promoting HBx protein degradation.
    Wang J; Yuan X; Wang Y; Zhang Y; Han M; Lu H; Liu S; Zhang Y; Ge F; Liu Y; Cheng J
    Virus Res; 2024 Mar; 341():199326. PubMed ID: 38253259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
    Li J; Zong L; Sureau C; Barker L; Wands JR; Tong S
    J Virol; 2016 Sep; 90(18):8302-13. PubMed ID: 27384660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation.
    Wei ZQ; Zhang YH; Ke CZ; Chen HX; Ren P; He YL; Hu P; Ma DQ; Luo J; Meng ZJ
    World J Gastroenterol; 2017 Sep; 23(34):6252-6260. PubMed ID: 28974891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat Shock Protein Family A Member 1 Promotes Intracellular Amplification of Hepatitis B Virus Covalently Closed Circular DNA.
    Tang L; An P; Zhao Q; Winkler CA; Chang J; Guo JT
    J Virol; 2023 Jan; 97(1):e0126122. PubMed ID: 36519896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes.
    König A; Döring B; Mohr C; Geipel A; Geyer J; Glebe D
    J Hepatol; 2014 Oct; 61(4):867-75. PubMed ID: 24845614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The retinoic acid receptor (RAR) α-specific agonist Am80 (tamibarotene) and other RAR agonists potently inhibit hepatitis B virus transcription from cccDNA.
    Nkongolo S; Nußbaum L; Lempp FA; Wodrich H; Urban S; Ni Y
    Antiviral Res; 2019 Aug; 168():146-155. PubMed ID: 31018112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally occurring 5' preS1 deletions markedly enhance replication and infectivity of HBV genotype B and genotype C.
    Li J; Li J; Chen S; Yuan Q; Zhang J; Wu J; Jiang Q; Wang Q; Xia NS; Zhang J; Tong S
    Gut; 2021 Mar; 70(3):575-584. PubMed ID: 32571971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Hepatitis B virus cccDNA replication by siRNA.
    Li GQ; Gu HX; Li D; Xu WZ
    Biochem Biophys Res Commun; 2007 Apr; 355(2):404-8. PubMed ID: 17300745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-α2b inhibits the ethanol enriched-HBV cccDNA through blocking a positive feedback loop of HBx/MSL2/cccDNA/HBV/HBx in liver.
    Liu Z; Wang J; Yuan H; Liu L; Bu Y; Zhao M; Yang G; Feng J; Liu Y; Li J; He Q; Zhang X
    Biochem Biophys Res Commun; 2020 Jun; 527(1):76-82. PubMed ID: 32446394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 System with Dual gRNAs Synergically Inhibit Hepatitis B Virus Replication.
    Fei L; Sun S; Yang Q; Huang Y; Li Q; Tao S; Chen L
    Discov Med; 2024 Jun; 36(185):1169-1179. PubMed ID: 38926103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hepatitis B virus cccDNA by siRNA in transgenic mice.
    Li G; Jiang G; Lu J; Chen S; Cui L; Jiao J; Wang Y
    Cell Biochem Biophys; 2014 Jul; 69(3):649-54. PubMed ID: 24569930
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Tu T; Zehnder B; Qu B; Urban S
    JHEP Rep; 2021 Feb; 3(1):100195. PubMed ID: 33385130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation.
    Tanaka T; Okuyama-Dobashi K; Murakami S; Chen W; Okamoto T; Ueda K; Hosoya T; Matsuura Y; Ryo A; Tanaka Y; Hagiwara M; Moriishi K
    Antiviral Res; 2016 Sep; 133():156-64. PubMed ID: 27515132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.